Literature DB >> 659883

In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors.

B A Blazar, F R Miller, G H Heppner.   

Abstract

Lymphoid cells were isolated by isokinetic gradient centrifugation from mouse mammary tumors and evaluated for their ability to affect tumor cell survival with the microcytotoxicity assay. In all experiments stimulation of the growth or survival of tumor cells was seen. This stimulation was not seen with separated lymphoid cells treated with anti-lymphocyte serum and complement. The lymphoid cells separated from tumors were more stimulatory than were lymph node cells; even toxic to the tumor cells, the separated tumor-associated lymphoid cells were markedly stimulatory. The gradient procedure had no effect on the activity of sensitized lymph node cells, but it did separate cytotoxicity and stimulation into different fractions.

Entities:  

Mesh:

Year:  1978        PMID: 659883

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Effects of isolated tumor lymphocytes alone and with adherent cells.

Authors:  B A Blazar; N Galili; E Klein
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 2.  Natural and induced immunity to mouse mammary tumors and the mammary tumor virus (MuMTV).

Authors:  O Stutman
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Characterization of tumor-associated lymphocytes in a series of mouse mammary tumor lines with differing biological properties.

Authors:  A M Rios; F R Miller; G H Heppner
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

4.  Purified mouse mammary tumor and lymphoid cells in immune assays.

Authors:  B A Blazar; F Vanky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  Modulation of tumour colony growth by irradiated accessory cells.

Authors:  A W Hamburger; C P White; F E Dunn
Journal:  Br J Cancer       Date:  1983-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.